Showing results (81-90 of 95) with videos related to
Sort By:
Pageof 10
Pharmaceutics|July 27, 2022
Using Dual Toll-like Receptor Agonism to Drive Th1-Biased Response in a Squalene- and α-Tocopherol-Containing Emulsion for a More Effective SARS-CoV-2 VaccineKristopher K Short, Stephanie K Lathrop, Clara J Davison, et al.RSC Pharmaceutics|June 12, 2026
Dual-adjuvant mucosal vaccine leveraging mast cell and TLR9 agonists for protection against poxvirus infectionConnor T Murphy, Grace L Williamson, Luis Ontiveros-Padilla, et al.Journal of Virology|March 8, 2019
Bridging Vaccine-Induced HIV-1 Neutralizing and Effector Antibody Responses in Rabbit and Rhesus Macaque Animal ModelsJustin Pollara, Dorothy I Jones, Tori Huffman, et al.Frontiers in Immunology|February 5, 2021
Fecal IgA, Antigen Absorption, and Gut Microbiome Composition Are Associated With Food Antigen Sensitization in Genetically Susceptible MiceJohanna M Smeekens, Brandi T Johnson-Weaver, Andrew L Hinton, et al.Frontiers in Immunology|August 7, 2024
Intranasal administration of a synthetic TLR4 agonist INI-2004 significantly reduces allergy symptoms following therapeutic administration in a murine model of allergic sensitizationKonner J Jackson, Cassandra Buhl, Shannon M Miller, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|May 29, 2025
A novel cationic liposome-formulated toll like receptor (TLR) 7/8 agonist enhances the efficacy of a vaccine against fentanyl toxicityFatima A Hamid, Nguyet-Minh Nguyen Le, Daihyun Song, et al.Bioorganic & Medicinal Chemistry|November 26, 2009
Isoxazole analogues bind the system xc- transporter: structure-activity relationship and pharmacophore modelSarjubhai A Patel, Trideep Rajale, Erin O'Brien, et al.ACS Applied Bio Materials|June 4, 2024
Promotion of Th17 Polarized Immunity via Co-Delivery of Mincle Agonist and Tuberculosis Antigen Using Silica NanoparticlesWalid M Abdelwahab, Bao Le-Vinh, Alexander Riffey, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|May 20, 2025
Broadly active intranasal influenza vaccine with a nanocomplex particulate adjuvant targeting mast cells and toll-like receptor 9Luis Ontiveros-Padilla, Dylan A Hendy, Erik S Pena, et al.Frontiers in Immunology|January 10, 2018
Identification and Characterization of Stimulator of Interferon Genes As a Robust Adjuvant Target for Early Life ImmunizationFrancesco Borriello, Carlo Pietrasanta, Jacqueline C Y Lai, et al.Pageof 10